全文获取类型
收费全文 | 1138篇 |
免费 | 78篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 7篇 |
妇产科学 | 17篇 |
基础医学 | 129篇 |
口腔科学 | 6篇 |
临床医学 | 123篇 |
内科学 | 317篇 |
皮肤病学 | 7篇 |
神经病学 | 137篇 |
特种医学 | 22篇 |
外科学 | 115篇 |
综合类 | 6篇 |
预防医学 | 60篇 |
眼科学 | 13篇 |
药学 | 162篇 |
中国医学 | 2篇 |
肿瘤学 | 90篇 |
出版年
2023年 | 15篇 |
2022年 | 20篇 |
2021年 | 43篇 |
2020年 | 33篇 |
2019年 | 34篇 |
2018年 | 36篇 |
2017年 | 33篇 |
2016年 | 27篇 |
2015年 | 39篇 |
2014年 | 34篇 |
2013年 | 51篇 |
2012年 | 72篇 |
2011年 | 96篇 |
2010年 | 35篇 |
2009年 | 27篇 |
2008年 | 45篇 |
2007年 | 59篇 |
2006年 | 37篇 |
2005年 | 37篇 |
2004年 | 37篇 |
2003年 | 23篇 |
2002年 | 24篇 |
2001年 | 15篇 |
2000年 | 18篇 |
1999年 | 9篇 |
1998年 | 7篇 |
1997年 | 8篇 |
1996年 | 8篇 |
1994年 | 8篇 |
1993年 | 9篇 |
1992年 | 24篇 |
1991年 | 21篇 |
1990年 | 22篇 |
1989年 | 14篇 |
1988年 | 14篇 |
1987年 | 6篇 |
1986年 | 15篇 |
1985年 | 22篇 |
1984年 | 15篇 |
1983年 | 11篇 |
1982年 | 14篇 |
1981年 | 7篇 |
1979年 | 11篇 |
1978年 | 6篇 |
1977年 | 10篇 |
1975年 | 5篇 |
1974年 | 5篇 |
1973年 | 5篇 |
1972年 | 6篇 |
1971年 | 6篇 |
排序方式: 共有1220条查询结果,搜索用时 31 毫秒
51.
52.
Mikkel A. Sørensen Valdemar L. Andersen Helle Westergren Hendel Charles Vriamont Corentin Warnier Julien Masset Tri Hien Viet Huynh 《Journal of labelled compounds & radiopharmaceuticals》2020,63(8):393-403
Prostate-specific membrane antigen (PSMA)-based radioligands for positron emission tomography (PET)/computed tomography (CT) studies represent the gold standard for detection of recurrent prostate cancer (PCa). [68Ga]PSMA-HBED-CC is a PET radiotracer suitable for detection of PCa, and its clinical use has become widespread over the last few years. In this contribution, we detail our GMP-compliant production of [68Ga]PSMA-HBED-CC using the Trasis miniAllinOne radiosynthesizer and report synthetic and clinical data for the first 100 productions of 2019. Additionally, we detail our efforts towards a GMP-compliant production of the radiotherapeutic [177Lu]PSMA-I&T using the same synthesis module. PSMA-based radioligand therapy (RLT) offers a possible future treatment in cases of metastatic castration-resistant PCa, and GMP-compliant routine production methods are therefore called for. This report highlights how PSMA-based agents for theranostic purposes can be conveniently produced at a single radiochemistry Good Manufacturing Practice (GMP) site, thereby facilitating optimized detection and treatment of PCa. 相似文献
53.
Beylergil Sinem Balta Noecker Angela M. Petersen Mikkel Gupta Palak Ozinga Sarah Walker Mark F. Kilbane Camilla McIntyre Cameron C. Shaikh Aasef G. 《Journal of neurology》2022,269(1):253-268
Journal of Neurology - Parkinson’s disease (PD) presents with visuospatial impairment and falls. It is critical to understand how subthalamic deep brain stimulation (STN DBS) modulates... 相似文献
54.
55.
Mortality and Causes of Death in Patients With Osteogenesis Imperfecta: A Register‐Based Nationwide Cohort Study
下载免费PDF全文
![点击此处可从《Journal of bone and mineral research》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Lars Folkestad Jannie Dahl Hald Vladimir Canudas‐Romo Jeppe Gram Anne Pernille Hermann Bente Langdahl Bo Abrahamsen Kim Brixen 《Journal of bone and mineral research》2016,31(12):2159-2166
Osteogenesis imperfecta (OI) is a hereditary connective tissue disease that causes frequent fractures. Little is known about causes of death and length of survival in OI. The objective of this work was to calculate the risk and cause of death, and the median survival time in patients with OI. This study was a Danish nationwide, population‐based and register‐based cohort study. We used National Patient Register data from 1977 until 2013 with complete long‐term follow‐up. Participants comprised all patients registered with the diagnosis of OI from 1977 until 2013, and a reference population matched five to one to the OI cohort. We calculated hazard ratios for all‐cause mortality and subhazard ratios for cause‐specific mortality in a comparison of the OI cohort and the reference population. We also calculated all‐cause mortality hazard ratios for males, females, and age groups (0 to 17.99 years, 18.00 to 34.99 years, 35.00 to 54.99 years, 55.00 to 74.99 years, and >75 years). We identified 687 cases of OI (379 women) and included 3435 reference persons (1895 women). A total of 112 patients with OI and 257 persons in the reference population died during the observation period. The all‐cause mortality hazard ratio between the OI cohort and the reference population was 2.90. The median survival time for males with OI was 72.4 years, compared to 81.9 in the reference population. The median survival time for females with OI was 77.4 years, compared to 84.5 years in the reference population. Patients with OI had a higher risk of death from respiratory diseases, gastrointestinal diseases, and trauma. We were limited by the lack of clinical information about phenotype and genotype of the included patients. Patients with OI had a higher mortality rate throughout their life compared to the general population. © 2016 American Society for Bone and Mineral Research. 相似文献
56.
57.
Mikkel Westen Mette W. Christoffersen Lars N. Jorgensen Trine Stigaard Thue Bisgaard 《Langenbeck's archives of surgery / Deutsche Gesellschaft fur Chirurgie》2014,399(1):65-69
Purpose
Umbilical and epigastric hernia repairs are minor, but are commonly conducted surgical procedures. Long-term results have only been sparsely investigated. Our objective was to investigate the risk of chronic complaints after a simple sutured repair for small umbilical and epigastric hernias.Methods
A retrospective cohort study with a 5-year questionnaire and clinical follow-up was conducted. Patients undergoing primary elective, open non-mesh umbilical or epigastric sutured hernia repair were included. Patients completed a structured questionnaire regarding chronic complaints during work and leisure activities using a verbal rating scale. The primary outcome was chronic complaints.Results
A total of 295 patients were included for analysis after a median of 5.0-year (range 2.8–8.0) follow-up period. Follow-up results were achieved from 262 of the included patients (90 % response rate). Up till 5.8 % of the patients reported moderate or severe pain and discomfort. Work and leisure activities were restricted in 8.5 and 10.0 % of patients, respectively. Patients with chronic complaints had a higher incidence of recurrence (clinical and reoperation), than patients with none or mild complaints (78.6 vs. 22.2 % (P?<?0.001)). The recurrence rate was significantly higher after a repair with absorbable suture (20.1 %) compared with non-absorbable suture repair (4.2 %) (P?<?0.001).Conclusion
We found that chronic complaints after a simple sutured umbilical or epigastric repair was in the level of 5.5 % and could in part be explained by recurrence. Furthermore, absorbable suture should be omitted to reduce risk of recurrence. 相似文献58.
59.
Relationship of glucose concentrations with PAI-1 and t-PA in subjects with normal glucose tolerance. 总被引:1,自引:0,他引:1
P E Heldgaard J J Sidelmann C Hindsberger N de F Olivarius J E Henriksen J Gram 《Diabetic medicine》2006,23(8):887-893
AIM: To study metabolic risk factors for the development of cardiovascular disease (CVD), including markers of the fibrinolytic system in relation to blood glucose levels in subjects with normal glucose tolerance and fasting blood glucose levels below 5.6 mmol/l. METHODS: Cross-sectional, community-based study from a primary health-care centre of adult subjects with normal glucose tolerance. Analysis of fasting and 2-h post-load blood glucose concentrations were centralized and related to anthropometric characteristics, metabolic variables, inflammatory markers, and coagulation and fibrinolytic variables. RESULTS: Increasing fasting blood glucose concentrations within the normal range in subjects with normal glucose tolerance were associated with increasing age, body mass index, and waist circumference, and with increasing concentrations of metabolic risk factors for development of CVD. After adjustment for gender, age, body mass index (BMI), and fasting insulin, levels of plasmin activator inhibitor (PAI-1) and tissue type plasminogen activator (t-PA) increased significantly with increasing levels of fasting glucose within the normal range (P = 0.012 and P < 0.0001, respectively). CONCLUSIONS: We found risk factors for CVD, specifically key components of the fibrinolytic system, PAI-1 and t-PA, increased with increasing fasting glucose levels even in subjects with normal glucose tolerance. This observation may help to explain the increased risk of CVD with increasing values of fasting glucose in the normal range. 相似文献
60.